The COVID chapter has been updated, overhauled, and refocused on the management of the sickest COVID patients (those requiring admission to ICU or stepdown units). The new chapter removes more basic information about COVID that we're all probably familiar with at this point (but the original, larger chapter is still available here).
The goal of the new chapter is to provide an easily readable and up-to-date approach to the sickest COVID patients. This is obviously a work in progress, which will continue to be updated based on continually emerging information.
A fresh overview podcast will be out really soon, so stay tuned for that.
-
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
- Pulmcrit wee: The cutoff razor - April 15, 2024
- PulmCrit Blogitorial – Use of ECGs for management of (sub)massive PE - March 24, 2024
- PulmCrit Wee: Propofol induced eyelid opening apraxia – the struggle is real - March 20, 2024
I wish you could have talked about anticoagulation.
Quick text from Lisbon, most of our ICUs have reached capacity so patients are arriving later to ICU. Still, any thoughts on the drawbacks of standard dexamethsone treatment for hypoxaemic patients? We are seeing an increase in VAP. More likely reflets pateints being admitted later and sicker and ICU being swamped and continuously expanding its capacity etc but wondering if anyone else is experiencing the same.
here is much more data info from the recently released RCT on anticoagulation – https://nhlbi-connects.org/documents/mpRCT%20Interim%20Presentation.pdf
Bravo thank you sir for all your hard work. Your dedication to medical education is truly respectable.
Recent and updated guidelines in hospitalized COVID patients.
We discussed , about,
Remdesvir ,Dexamethasone, Tocilizumab
Fabipiravir, Plasma
Management of respiratory failure
DVT
And many more..
If you like the content..
please share and subscribe.. that will be of immense help..
https://youtu.be/bqHgW66EcJk
Josh is it ok to give methylprednisolone 125 mg iv daily (once daily) to covid 19 pts. My colleagues have bashed me saying i should use decadron 6 qday or methylprednisolone 60 q6. I challenged them to literature but they couldn’t find any to back of their claims. Can you provide some insight. Most literature i have found states that Solu-Medrol does a better job of treating COVID-19 due to the higher dose of steroid given. Colleagues have also suggested I try decadron q6. I’ve also tried methylprednisolone 125IVQ 12 as well